Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cambridge Healthtech Institute's Third Annual Anti-inflammatories: small Molecules Meeting, April 17(th) - 18(th) 2012, San Diego, USA.
Acute disseminated encephalomyelitis after treatment of Plasmodium vivax malaria.
Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
The Retinal Nerve Fiber Layer of Patients With Neuromyelitis Optica and Chronic Relapsing Optic Neuritis is More Severely Damaged than Patients With Multiple Sclerosis.
Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.
Review of laquinimod and its therapeutic potential in multiple sclerosis.
Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
[110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)].
Differential Pro-Inflammatory Responses of Astrocytes and Microglia Involve STAT3 Activation in Response to 1800 MHz Radiofrequency Fields.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Bilirubin-induced neural impairment: A special focus on myelination, age-related windows of susceptibility and associated co-morbidities.
DNA Damage, DNA Repair, Aging, and Neurodegeneration.
[Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
Utilization of physical rehabilitation among people with multiple sclerosis.
Ambulation in adults with central neurologic disorders.
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
Erratum to: Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Anti-aquaporin-4 antibody-positive dorsal midbrain syndrome.
Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis.
Both positive and negative effects on immune responses by expression of a second class II MHC molecule.
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.
The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration.
Perspectives of the relationship between IL-7 and autoimmune diseases.
Therapeutic Effect of Transplanted Human Wharton's Jelly Stem Cell-Derived Oligodendrocyte Progenitor Cells (hWJ-MSC-derived OPCs) in an Animal Model of Multiple Sclerosis.
Walking Speed and Health-Related Quality of Life in Multiple Sclerosis.
Pages
« first
‹ previous
…
505
506
507
508
509
510
511
512
513
…
next ›
last »